4 days ago
DataMEDS AI (MEDS) Stock Soars 87% Following Helomics Cancer Lab Acquisition
DataMEDS AI (MEDS) stock soared 87% after finalizing its $1.5M Helomics acquisition, gaining access to the $40B U.S. cancer diagnostics market.
The post DataMEDS AI (MEDS) Stock Soars 87% Following Helomics Cancer Lab Acquisition appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Crypto platform Gemini’s stock is down 80% from its IPO. That’s reviving takeove...
- 4 hours ago
Bitcoin Price Prediction: When Will BTC Price Hit $100K?
- 4 hours ago
Crypto traders braced for a total wipeout this week but Bitcoin had other plans
- 4 hours ago
Coinbase, Robinhood, Circle could be early winners of SEC's tokenized-stock push...
- 8 hours ago
Ethereum Staking Demand Outpaces Exits as Entry Queue Surges